Evaluation of drug-related hypersensitivity reactions in children

被引:0
|
作者
Martín-Muñoz, F [1 ]
Moreno-Ancillo, A [1 ]
Domínguez-Noche, C [1 ]
Díaz-Pena, JM [1 ]
García-Ara, C [1 ]
Ojeda, JA [1 ]
机构
[1] Univ Madrid, Hosp La Paz, Childhood Allergy Serv, Madrid 3, Spain
关键词
childhood; drug allergy; drug challenge; skin testing; beta-lactam antibiotics; aspirin; sulfonamides; amoxicillin;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Patients with drug reactions are often referred to allergists for "allergy". Shin testing and clinical history seem to have a good negative predictive value, however, although drug challenge could be dangerous, it is the only way to confirm the diagnosis. We aimed to demonstrate that most children with a history of non-life-threatening drug reactions do not have a true drug allergy and examined the use of drug challenge in childhood. Patients with reactions were referred to our clinic by pediatricians. In 1 year, 354 reactions were studied in 239 children. Patients were classified according to their positive or negative history of drug allergy: Skin prick testing was done in all cases. Exclusion criteria for challenge included drug anaphylaxis, Stevens-Johnson syndrome, systemic reactions with severe concomitant illness, beta-inhibifor drug therapy or positive skin test to the implicated drug with a positive history It was found that the beta-lactam antibiotics were involved in 50% of suspected reactions, aspirin in 10% and sulfonamides in 9%. Histories were considered positive only in 25%. Drug challenges confirmed only 4% of all reactions. If was concluded that drug challenge may be the gold standard for most childhood reactions that are considered to be allergic, non-life-threatening and drug-related. Only 4% of these suspected reactions were exclusively caused by drug allergy.
引用
收藏
页码:172 / 177
页数:6
相关论文
共 50 条
  • [21] Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions
    Wolfson, Anna R.
    Banerji, Aleena
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (01) : 16 - 21
  • [22] Drug-related problem in children with chronic kidney disease
    Norkasihan Ibrahim
    Ian CK Wong
    Susan Patey
    Stephen Tomlin
    Manish D Sinha
    Yogini Jani
    Pediatric Nephrology, 2013, 28 : 25 - 31
  • [23] DRUG-RELATED COMPLICATIONS IN INFANTS AND CHILDREN - IMAGING FEATURES
    KASSNER, EG
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1991, 157 (05) : 1039 - 1049
  • [24] Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series
    Nakamura, Yukihiro
    Takimoto, Takayuki
    Kobayashi, Takehiko
    Tachibana, Kazunobu
    Kasai, Takahiko
    Akira, Masanobu
    Arai, Toru
    Inoue, Yoshikazu
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 34
  • [25] Drug-related problem in children with chronic kidney disease
    Ibrahim, Norkasihan
    Wong, Ian C. K.
    Patey, Susan
    Tomlin, Stephen
    Sinha, Manish D.
    Jani, Yogini
    PEDIATRIC NEPHROLOGY, 2013, 28 (01) : 25 - 31
  • [26] Involvement of interleukin-5 in drug-related hypersensitivity syndrome with eosinophilia.
    ChoquetKastylevsky, G
    Intrator, L
    Bocquet, H
    Revuz, J
    Roujeau, JC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 172 - 172
  • [27] When is a drug-related death not a drug-related death? Implications for current drug-related death policies in the UK and Europe
    Beynon, Caryl M.
    Bellis, Mark A.
    Church, Elaine
    Neely, Sue
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2007, 2 (1)
  • [28] When is a drug-related death not a drug-related death? Implications for current drug-related death policies in the UK and Europe
    Caryl M Beynon
    Mark A Bellis
    Elaine Church
    Sue Neely
    Substance Abuse Treatment, Prevention, and Policy, 2
  • [29] Drug-Related Adverse Reactions in Pediatric Inflammatory Bowel Disease
    Losa, Ana
    Gomes, Rita
    Mourao, Francisco Ribeiro
    Cardoso, Sandra Soares
    Vieira, Paula Manuel
    Correia, Mario Rui
    Silva, Helena Moreira
    Silva, Gisela
    Tavares, Marta
    Silva, Ermelinda Santos
    Lima, Rosa
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (01): : 103 - 110
  • [30] THE PREVALENCE OF DRUG-RELATED ADVERSE REACTIONS AMONG HYPERTENSIVE PATIENTS
    Stolarz-Skrzypek, Katarzyna
    Bijak, Magdalena
    Olszanecka, Agnieszka
    Wojciechowska, Wiktoria
    Czarnecka, Danuta
    JOURNAL OF HYPERTENSION, 2021, 39 : E42 - E43